Detailed Mechanism Funding and Narrative

Years of mechanism: 2010 2011 2012 2013 2014 2015 2016

Details for Mechanism ID: 9639
Country/Region: Tanzania
Year: 2014
Main Partner: Bugando Medical Centre
Main Partner Program: NA
Organizational Type: FBO
Funding Agency: HHS/CDC
Total Funding: $3,376,143 Additional Pipeline Funding: N/A

NOTE: The following is taken from summaries released by PEPFAR on the PEPFAR Data Dashboard. They are incomplete summary paragraphs only and do not contain the full mechanism details. When the full narratives are released, we will update the mechanism pages accordingly.

Bugando Medical Centre (BMC) is a faith based organization working with facilities on maternal and neonatal mortality reduction and scale up of HIV care and treatment services, PMTCT, HTC, and VMMC provision. Programs are linked by referrals, integration, and coordination to ensure synergy and efficient utilization of resources. The catchment regions are Mwanza, Shinyanga, Tabora, Kigoma, Kagera and Mara, reaching a population of 16 million. This is a high HIV burden area, with an aggregate prevalence of about 5%. The specific programmatic areas in which BMC will work are: strengthening quality of HIV care and treatment and PMTCT program services; increasing access to HIV testing in facilities for key populations; building capacity to provide VMMC services to men aged 10-29; and implementing a maternal mortality reduction program in 35 hospitals within the target regions. The goals are linked to NMSF, PF and GHI, and will help to achieve the framework targets. BMC’s activities will be implemented in a network model, linking district and regional stakeholders, to capitalize on synergy, foster cooperation, and leverage resources from other partners. By strengthening district health systems, promoting program ownership, and engaging in planning and budgeting for project activities, districts will be able to take over these programs. BMC will strengthen its M&E unit focusing on human capacity development to ensure data quality, analysis and evaluation. This will be achieved through on-site TA in the form of training and supportive supervision.

BMC’s FY 2013 EA DSP UEs were reviewed and found to be comparable to similar partners; expenditures reported were in line with programmatic priorities and approved budgets.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $0
Care: TB/HIV (HVTB) $20,062
Care: Pediatric Care and Support (PDCS) $5,570
Laboratory Infrastructure (HLAB) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $1,748,000
Testing: HIV Testing and Counseling (HVCT) $300,000
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $311,343
Treatment: Adult Treatment (HTXS) $968,210
Treatment: Pediatric Treatment (PDTX) $22,958
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV By PEP service provision (related to sexual violence services provided) 2015 36
GEND_GBV Number of people receiving post-GBV care 2015 36
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2015 28,850
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2015 19,234
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2015 43,276
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2015 28,850
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2015 100,210
HTS_TST Sum of Aggregated Age/Sex <15 2015 48,084
HTS_TST Sum of Aggregated Age/Sex 15+ 2015 72,126
HTS_TST Sum of Aggregated Age/Sex disaggregates 2015 120,210
PMTCT_ARV Life-long ART (including Option B+) 2015 474
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2015 558
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2015 422
PMTCT_ARV Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2015 284
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2015 190
PMTCT_ARV Sum of New and Current disaggregates 2015 474
PMTCT_ARV Sum of Regimen Type disaggregates 2015 474
PMTCT_EID By infants who received a virologic test within 2 months of birth 2015 312
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2015 134
PMTCT_EID Number of HIV- positive pregnant women identified during the reporting period (include known HIV-positive women at entry into PMTCT) 2015 558
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2015 514
PMTCT_EID Sum of Infant Age disaggregates 2015 446
PMTCT_STAT By: Known positives at entry 2015 167
PMTCT_STAT By: Number of new positives identified 2015 391
PMTCT_STAT Number of new ANC and L&D clients 2015 4,172
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2015 1,516
PMTCT_STAT Sum of Positives Status disaggregates 2015 558
SITE_SUPP By program area/support type: HTC Direct Service Delivery (DSD) 2015 1
SITE_SUPP By program area/support type: PHDP/Family Planning & Integration Direct Service Delivery (DSD) 2015 1
SITE_SUPP By program area/support type: PMTCT Direct Service Delivery (DSD) 2015 1
SITE_SUPP By program area/support type: VMMC Direct Service Delivery (DSD) 2015 1
SITE_SUPP Number of unique sites supported by PEPFAR 2015 1
TX_CURR Aggregated Age/Sex: <1 Female 2015 398
TX_CURR Aggregated Age/Sex: <1 Male 2015 181
TX_CURR Aggregated Age/Sex: <15 Female 2015 1,149
TX_CURR Aggregated Age/Sex: <15 Male 2015 566
TX_CURR Aggregated Age/Sex: 15+ Female 2015 4,231
TX_CURR Aggregated Age/Sex: 15+ Male 2015 2,084
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2015 8,030
TX_CURR Sum of Aggregated Age/Sex <15 2015 1,715
TX_CURR Sum of Aggregated Age/Sex 15+ 2015 6,315
TX_CURR Sum of Aggregated Age/Sex disaggregates 2015 8,030
TX_NEW Aggregated Grouping by Age: <1 Male 2015 39
TX_NEW Aggregated Grouping by Age/Sex: <1 Female 2015 79
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2015 347
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2015 171
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2015 2,288
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2015 1,127
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2015 3,932
TX_NEW Pregnancy status 2015 45
TX_NEW Sum of Aggregated Age/Sex disaggregates 2015 3,933
VMMC_CIRC By Age: 10-14 2015 10,557
VMMC_CIRC By Age: 15-19 2015 5,891
VMMC_CIRC By Age: 20-24 2015 4,503
VMMC_CIRC By Age: 25-49 2015 3,754
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2015 27,965
VMMC_CIRC Sum of age disaggregates 2015 27,965
Cross Cutting Budget Categories and Known Amounts Total: $841,404
Gender: Gender Equality $100,000
Changing harmful gender norms and promoting positive gender norms
Implementation
Human Resources for Health $741,404
Key Issues Identified in Mechanism
Child Survival Activities
Mobile Populations
Family Planning